This Executive Summary is intended to assist stakeholders in navigating the data outlined within the
2019 Testing Figures Report (2019 Report) and to highlight overall trends.
The 2019 Report summarizes the results of all the samples WADA-accredited Laboratories analyzed
and reported into WADA’s Anti-Doping Administration and Management System (ADAMS) in 2019. This
is the fifth set of global testing under the version of the World Anti-Doping Code (Code) that came into
effect in January 2015. The 2019 Report – which includes this Executive Summary and sub-reports by
Laboratory, Sport, Testing Authority (TA) and Athlete Biological Passport (ABP) Blood Analysis –
includes in- and out-of-competition urine samples; blood and ABP blood data; and, the resulting
Adverse Analytical Findings (AAFs) and Atypical Findings (ATFs).